The Technical Analyst
HTG Molecular Diagnostics [HTGM]
Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research
HTG Molecular Diagnostics Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.480
America/New_York / 14 jun 2023 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1.063 mill |
| EPS: | -17.10 |
| P/E: | -0.0281 |
| Earnings Date: | Aug 09, 2023 |
| SharesOutstanding: | 2.21 mill |
| Avg Daily Volume: | 0.254 mill |
| RATING 2023-06-14 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/21 | 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.0281 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.0281 | industry: PE 18.71 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.166 - 0.794 ( +/- 65.42%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-06-08 | Barat Stephen | Sell | 888 | Common Stock |
| 2023-03-31 | Barat Stephen | Sell | 52 | Common Stock |
| 2023-02-02 | Barat Stephen | Sell | 0 | Common Stock |
| 2023-02-02 | Barat Stephen | Sell | 4 166 | Stock Option (right to buy) |
| 2023-02-02 | Barat Stephen | Sell | 2 083 | Stock Option (right to buy) |
| INSIDER POWER |
|---|
| 93.95 |
| Last 98 transactions |
| Buy: 3 245 171 | Sell: 16 674 |
Forecast:
01:40 - $1.548
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.480 (0.00% ) |
| Volume | 0.725 mill |
| Avg. Vol. | 0.254 mill |
| % of Avg. Vol | 285.70 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For HTGM
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
HTGM
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
Last 10 Buy Signals
Latest Press Releases
2022-12-28 08:00:00 - Press Release
Htg Molecular Diagnostics Provides Highlights Of Its Second Event In Drug Discovery Kol Webcast Series
Tucson, ariz., dec. 28, 2022 (globe newswire) -- htg molecular diagnostics, inc. (nasdaq: htgm) (htg), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, provides here a summary of its second htg therapeutics key opinion leader (kol) webinar: “the role of rna profiling in drug discovery and analysis,” hosted on tuesday, december 13, 2022.
2022-12-09 08:01:00 - Press Release
Htg Molecular Diagnostics Announces The Next Event In Its Rna Profiling In Drug Discovery Kol Webcast Series
Tucson, ariz., dec. 09, 2022 (globe newswire) -- htg molecular diagnostics, inc. (nasdaq: htgm) (htg), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today announced it will host its next htg therapeutics key opinion leader (kol) webinar: “the role of rna profiling in drug discovery and analysis”, on tuesday, december 13, 2022 at 11:00 am eastern standard time.
2022-05-17 16:05:00 - Press Release
Htg Molecular Diagnostics To Participate In The H.c. Wainwright Global Investment Conference
Tucson, ariz., may 17, 2022 (globe newswire) -- htg molecular diagnostics, inc. (nasdaq: htgm) (htg), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that management will participate virtually in the h.c. wainwright global investment conference being held may 23-26, 2022.
2021-10-05 08:00:00 - Press Release
Htg Expands Therapeutics Team
Veteran drug developer stephen barat, ph.d. joins to head company's therapeutics division veteran drug developer stephen barat, ph.d. joins to head company's therapeutics division
2021-09-08 16:10:00 - Press Release
Htg Molecular Diagnostics To Present At H.c. Wainwright's 23rd Annual Global Investment Conference
Tucson, ariz., sept. 08, 2021 (globe newswire) -- htg molecular diagnostics, inc. (nasdaq: htgm) (htg), a life science company whose mission is to advance precision medicine, today announced that company management will participate in h.c. wainwright's 23rd annual global investment conference, being held september 13th – 15th, 2021.
Latest News
2023-06-06 09:17:54 - InvestorPlace
Why Is HTG Molecular Diagnostics (HTGM) Stock Down 42% Today?
HTG Molecular Diagnostics (NASDAQ: HTGM ) stock is falling on Tuesday after the company announced a Chapter 11 bankruptcy filing. According to this filing, HTG Molecular Diagnostics will operate as a “debtor-in-possession” business during the bankruptcy.
2022-12-28 08:00:00 - GlobeNewsWire
HTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery KOL Webcast Series
TUCSON, Ariz., Dec. 28, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, provides here a summary of its second HTG Therapeutics key opinion leader (KOL) webinar: “The Role of RNA Profiling in Drug Discovery and Analysis,” hosted on Tuesday, December 13, 2022.
2022-12-21 10:57:19 - InvestorPlace
What Is Going on With HTG Molecular Diagnostics (HTGM) Stock Today?
Some investors of HTG Molecular Diagnostics (NASDAQ: HTGM ) got a big surprise today. Due to a reverse share split, HTGM stock is suddenly more expensive.
2022-12-19 13:00:33 - PennyStocks
3 Top Biotech Penny Stocks Under $3 To Watch Right Now
Biotech penny stocks to watch right now. The post 3 Top Biotech Penny Stocks Under $3 To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-12-14 11:51:20 - PennyStocks
Penny Stocks To Buy Now? 10 Stocks Under $1 To Watch
2022-12-13 06:00:00 - PennyStocks
How to Conduct Due Diligence on Penny Stocks, 3 Tips
Need help researching penny stocks to buy? Use these tips The post How to Conduct Due Diligence on Penny Stocks, 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-12-12 14:51:07 - PennyStocks
7 Hot Penny Stocks Under $1 To Watch This Week
Penny stocks to watch trading under $1 right now. The post 7 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-12-12 13:58:57 - MarketBeat
Three Small-Cap Biotech Stocks to Consider Now
This article looks at three small-cap biotech companies with stock prices that are making significant moves and have a bright outlook for 2023
2022-12-12 11:18:53 - InvestorPlace
Dear HTGM Stock Fans, Mark Your Calendars for Dec. 13
HTG Molecular Diagnostics (NASDAQ: HTGM ) stock is rocketing higher on Monday as investors prepare for a major event on Dec. 13. That's when the company will hold its HTG Therapeutics key opinion leader webinar.
2022-12-09 08:01:00 - GlobeNewsWire
HTG Molecular Diagnostics Announces the Next Event in its RNA Profiling in Drug Discovery KOL Webcast Series
TUCSON, Ariz., Dec. 09, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today announced it will host its next HTG Therapeutics key opinion leader (KOL) webinar: “The Role of RNA Profiling in Drug Discovery and Analysis”, on Tuesday, December 13, 2022 at 11:00 am Eastern Standard Time.